Revolutionary Injection Reduces Harmful Belly Fat by 12%

WHO:

Fox News - Scientists involved in the development of the CBL-514 injection.

WHAT:

Fox News - The CBL-514 injection reduces visceral fat by 12% in early human trials.

Science Daily - The injection triggers apoptosis specifically in fat cells, leading to the destruction of these cells.

WHERE:

Fox News - The trials for the CBL-514 injection are conducted in a clinical setting, though specific locations are not mentioned.

WHEN:

Science Daily - The research suggests potential future applications for treating obesity and preventing weight regain after stopping weight loss drugs like Ozempic and Wegovy.

WHY:

Science Daily - The injection aims to provide a new path for treating obesity and addressing insulin resistance.

HOW:

Fox News - The CBL-514 injection works by inducing apoptosis in fat cells, which leads to a reduction in harmful belly fat.

(UPDATED October 12, 2026 10:09 UTC)

Scientists have developed a new injection called CBL-514, which has shown promising results in early human trials by reducing visceral fat by twelve percent. This injection works by triggering apoptosis specifically in fat cells, leading to their destruction, and it aims to offer a new approach to treating obesity and addressing insulin resistance. Researchers suggest that CBL-514 could have potential applications for preventing weight regain after discontinuing weight loss medications like Ozempic and Wegovy.